ClinicalTrials.gov
public full text
Public Domain
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
OBJECTIVES: I. Determine the safety and efficacy of tobramycin in patients with cystic fibrosis who are chronically colonized with Pseudomonas aeruginosa. II. Determine whether this treatment produces tobramycin-resistant bacteria at a frequency different from the placebo group and whether the emergence of resistance is associated with a lack of clinical response.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis#1060772
- Airway Microbiome of Cystic Fibrosis Patients#872030
- Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis#825725
- Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections#146218
- Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis#127642
Record · ID 1057655
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive